| 000 | 01583 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516001906.0 | ||
| 264 | 0 | _c20110118 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1361-6528 | ||
| 024 | 7 |
_a10.1088/0957-4484/21/40/405101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHsu, Shu-Hui | |
| 245 | 0 | 0 |
_aPhysicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. _h[electronic resource] |
| 260 |
_bNanotechnology _cOct 2010 |
||
| 300 |
_a405101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApomorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain _xcytology |
| 650 | 0 | 4 | _aCalorimetry, Differential Scanning |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 |
_aImaging, Three-Dimensional _xmethods |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLipids _xchemistry |
| 650 | 0 | 4 |
_aLuminescent Measurements _xmethods |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 |
_aNanostructures _xchemistry |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aWen, Chih-Jen | |
| 700 | 1 | _aAl-Suwayeh, S A | |
| 700 | 1 | _aChang, Hui-Wen | |
| 700 | 1 | _aYen, Tzu-Chen | |
| 700 | 1 | _aFang, Jia-You | |
| 773 | 0 |
_tNanotechnology _gvol. 21 _gno. 40 _gp. 405101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1088/0957-4484/21/40/405101 _zAvailable from publisher's website |
| 999 |
_c20155951 _d20155951 |
||